US BANCORP \DE\ - EPIZYME INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of EPIZYME INC
ValueSharesWeighting
Q1 2022$2,000
-75.0%
1,547
-55.4%
0.00%
Q4 2021$8,000
-50.0%
3,472
+11.4%
0.00%
Q3 2021$16,000
-15.8%
3,117
+36.3%
0.00%
Q2 2021$19,000
+35.7%
2,287
+41.5%
0.00%
Q1 2021$14,000
+7.7%
1,616
+43.6%
0.00%
Q4 2020$13,000
-7.1%
1,1250.0%0.00%
Q3 2020$14,000
-41.7%
1,125
-43.8%
0.00%
Q4 2016$24,000
+20.0%
2,0000.0%0.00%
Q3 2016$20,0000.0%2,0000.0%0.00%
Q2 2016$20,000
-16.7%
2,0000.0%0.00%
Q1 2016$24,000
-25.0%
2,0000.0%0.00%
Q4 2015$32,000
+23.1%
2,0000.0%0.00%
Q3 2015$26,0002,0000.00%
Other shareholders
EPIZYME INC shareholders Q3 2023
NameSharesValueWeighting ↓
RP Management, LLC 9,166,667$109,358,00016.39%
Burrage Capital Management LLC 1,002,528$11,960,0009.44%
Foresite Capital Management III, LLC 998,278$11,909,0008.87%
MPM BioImpact LLC 2,854,737$34,057,0008.20%
Palo Alto Investors LP 6,403,600$76,395,0004.19%
Foresite Capital Management II, LLC 862,402$10,288,0002.24%
Redmile Group, LLC 8,311,633$99,158,0001.82%
Pier Capital, LLC 574,299$6,851,0001.00%
Foresite Capital Management I, LLC 243,759$2,908,0000.82%
Rock Springs Capital Management LP 2,551,659$30,441,0000.77%
View complete list of EPIZYME INC shareholders